David Parrot

Chief Financial Officer

Chief Financial Officer at Scribe Therapeutics, Inc., filing insider transactions on 2026-07-23.

Total Purchases

$20K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-07-23

Last: 2026-07-23

Companies

Scribe Therapeutics, Inc.

Other Reporting Insiders at Scribe Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-23	SCTX	Purchase	1,333	$15.00	$20K	1,333	SEC ↗

David Parrot (Scribe Therapeutics, Inc.) Insider Trades | Tormere